Quick Dispatch:
Your soul trial oral semaglutide cardiovascular outcomes results 2025 nejm Oral Semaglutide and Cardiovascular Outcomes in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your soul trial oral semaglutide cardiovascular outcomes results 2025 nejm Oral Semaglutide and Cardiovascular Outcomes in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial ships.
Need Help?
Questions about soul trial oral semaglutide cardiovascular outcomes results 2025 nejm Oral Semaglutide and Cardiovascular Outcomes in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for soul trial oral semaglutide cardiovascular outcomes results 2025 nejm Oral Semaglutide and Cardiovascular Outcomes in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial in your area.
Trial Scorecard: SOUL
26.95
Heart disease is the #1 cause of death in type 2 diabetes — and for the first time, an oral GLP-1 drug has been proven to reduce major cardiovascular events The SOUL
26.91
Effect of Oral Semaglutide on Cardiovascular Outcomes in Type 2 Diabetes by Extent of Vascular Disease
20.81
Frontiers
29.23
SOUL (Semaglutide cardiOvascular oUtcomes triaL) in individuals with
25.11
Oral semaglutide found to lower risk of heart failure events in people with type 2 diabetes
29.14
Oral Semaglutide and Cardiovascular Outcomes in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial
20.05
